InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,353.44
(
0.17%
)
Post# of 32544
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ETARHEEL77

Send PM Follow Ignore
Followers 10
Posts 275
Boards Moderated 0
Alias Born 09/30/2009

ETARHEEL77

Re: None

Wednesday, 09/25/2013 10:22:27 AM

Wednesday, September 25, 2013 10:22:27 AM

Post# of 32544
"Michael Walter, the program manager for BioWatch, told the committee that the department's cost-benefit analysis for BioWatch Gen-3 would be complete by this fall.

Read more: BioWatch Gen-3 may be too costly, CDC official says - FierceHomelandSecurity http://www.fiercehomelandsecurity.com/story/biowatch-gen-3-may-be-too-costly-cdc-official-says/2013-06-20#ixzz2fukRFjAF
Subscribe at FierceHomelandSecurity"
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up